Clinical trials
Observational Diabetic Retinopathy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 8 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Unknown status | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 10 |
| Digital Diagnostics, Inc. | 4 |
| Eyenuk, Inc. | 4 |
| University of Alabama at Birmingham | 4 |
| Regeneron Pharmaceuticals | 3 |
| Duke University | 2 |
| Jaeb Center for Health Research | 2 |
| Oregon Health and Science University | 2 |
| RETINA-AI Health, Inc. | 2 |
| VisionQuest Biomedical LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 66 |
| Macular Degeneration | 18 |
| Diabetes Mellitus | 11 |
| Retinal Diseases | 10 |
| Retinal Vein Occlusion | 8 |
| Macular Edema | 4 |
| Glaucoma | 3 |
| Uveitis | 3 |
| Blindness | 2 |
| Cataract | 2 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.